(2) SGLT2 inhibition induced ROS-mediated DNA damage and ATM/CHK2 activation, which lead to G1/S phase transition arrest and increased apoptosis in thyroid cancer. The gene discussed is SLC5A2; the disease is thyroid gland carcinoma.